Biomedical Engineering Reference
In-Depth Information
54. Nagaki M, Shimura S, Irokawa T, Sasaki T, Oshiro T, Nara M, et al.
Bradykinin regulation of airway submucosal gland secretion:
role of
bradykinin receptor subtype. Am J Physiol 1996; 270:L907-L913.
55. Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ.
Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for
ACE-inhibitor cough. Nature Med 1996; 2:814-817.
56. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, et
al. Elevated substance P content in induced sputum from patients with asthma
and patients with chronic bronchitis. Am J Respir Crit Care Med 1995;
151:613-617.
57. Germonpre PR, Bullock GR, Lambrecht BN, Van DVV, Luyten WH, Joos
GF, et al. Presence of substance P and neurokinin 1 receptors in human
sputum macrophages and U-937 cells. Eur Respir J 1999; 14:776-782.
58. Tokuyama K, Kuo H-P, Rohde JAL, Barnes PJ, Rogers DF. Neural control
of goblet cell secretion in guinea pig airways. Am J Physiol 1990; 259:
L108-L115.
59. Rogers DF, Aursudkij B, Barnes PJ. Effects of tachykinins on mucus secretion
on human bronchi in vitro. Eur J Pharmacol 1989; 174:283-286.
60. Phillips JE, Hey JA, Corboz MR. Tachykinin NK
3
and NK
1
receptor activa-
tion elicits secretion from porcine airway submucosal glands. Br J Pharmacol
2003; 138:254-260.
61. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev
Immunol 2000; 18:217-242.
62. Proudfoot AE. Chemokine receptors: multifaceted therapeutic targets. Nat
Rev Immunol 2002; 2:106-115.
63. Gutierrez-Ramos JC, Lloyd C, Kapsenberg ML, Gonzalo JA, Coyle AJ.
Non-redundant functional groups of chemokines operate in a coordinate
manner during the inflammatory response in the lung. Immunol Rev 2000;
177:31-42.
64. Olson TS, Ley K. Chemokines and chemokine receptors in leukocyte traffick-
ing. Am J Physiol Regul Integr Comp Physiol 2002; 283:R7-R28.
65. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev
Immunol 2001; 1:108-116.
66. Panina-Bordignon P, D'Ambrosio D. Chemokines and their receptors in
asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med
2003; 9:104-110.
67. Barnes PJ. New treatments for COPD. Nature Rev Drug Disc 2002; 1:
437-445.
68. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8
and tumor necrosis factor-a in induced sputum from patients with chronic
obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;
153:530-534.
69. Yamamoto C, Yoneda T, Yoshikawa M, Fu A, Tokuyama T, Tsukaguchi K,
et al. Airway inflammation in COPD assessed by sputum levels of interleu-
kin-8. Chest 1997; 112:505-510.
